Hepatocellular carcinoma: Clinicopathological profile and challenges of management in a resource-limited setting

World Journal of Surgical Oncology

Volumn 12, Issue 1, 2014, Pages

  Jaka, Hyasinta ^a   Mshana, Stephen E ^a   Rambau, Peter F ^a   Masalu, Nestory ^a   Chalya, Phillipo L ^a   Kalluvya, Samuel E ^a  

^a CATHOLIC UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

Author keywords

Challenges; Clinicopathological; Hepatocellular carcinoma; Resource limited setting; Tanzania

Indexed keywords

ADOLESCENT; ADULT; AGED; CANCER STAGING; CARCINOMA, HEPATOCELLULAR; DEVELOPING COUNTRY; DISEASE MANAGEMENT; ECONOMICS; FEMALE; FOLLOW UP; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HUMAN; LENGTH OF STAY; LIVER NEOPLASMS; MALE; METASTASIS; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; RISK FACTOR; SECONDARY; SURVIVAL RATE; YOUNG ADULT; ADVANCED CANCER; ALCOHOL CONSUMPTION; ARTICLE; BLOOD CLOTTING DISORDER; CD4 LYMPHOCYTE COUNT; COMORBIDITY; DISEASE SEVERITY; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; TANZANIA;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; COMBINED MODALITY THERAPY; DEVELOPING COUNTRIES; DISEASE MANAGEMENT; FEMALE; FOLLOW-UP STUDIES; HEALTH RESOURCES; HEALTH SERVICES ACCESSIBILITY; HUMANS; LENGTH OF STAY; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; YOUNG ADULT;

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

EID: 84905394569     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-12-246     Document Type: Article

References (39)

1. Parkin DM, Brany F, Ferlay J, Pisani P. Global cancer statistics 2002. CA Cancer J Clin 2005, 55:74-108.
2. Kew MC. Epidemiology of hepatocellular carcinoma in sub-Saharan Africa. Ann Hepatol 2013, 12:173-102.
3. Seleye-Fubara D, Jebbin NJ. Hepatocellular carcinoma in Port Harcourt, Nigeria: clinicopathologic study of 75 cases. Ann Afr Med 2007, 6:54-57.
4. Van-Rensburg SJ, Cook-mazaffari P, Van Schalkwyrk DJ, VanDerwatt JJ, Vincent TJ, Purshase IF. Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei. Br J Cancer 1985, 51:713-726.
5. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and HBV a prospective study of 22707 men in Taiwan. Lancet 1981, 2:1129-1133.
6. Olubuyide IO, Bamgboye EA. A case-control study of the current role of cigarette smoking and alcohol consumption in primary liver cell carcinoma in Nigerians. Afr J Med Sci 1990, 19:191-194.
7. El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004, 127:27-34.
8. Moradpour D, Wands JR. The molecular pathogenesis of hepatocellular carcinoma. J Viral Hepat 1994, 1:17-31.
9. Okuda K. Hepatocellular carcinoma: recent progress. Hepatology 1992, 15:948-963.
10. Kirk GD, Camus-Randon AM, Mendy M, Goedert JJ, Merle P, Trepo C, Brechot C, Hainaut P, Montesano R. Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma. J Natl Cancer Inst 2000, 92:148-153.
11. Ndububa DA, Ojo OS, Adeodu OO, Adetiloye VA, Olasode BJ, Famurewa OC, Durosinmi MA, Agbakwuru AE. Primary hepatocellular carcinoma in Ile Ife, Nigeria: a prospective study of 154 cases. Nig J Med 2001, 10:59-62.
12. Mustapha SK, Pindiga UH. Prevalence of Hepatitis B virus in patients with hepatocellular carcinoma in Gombe, North-eastern Nigeria. Sahel Med J 2003, 6:104-106.
13. Kew MC. Challenges of managing hepatocellular carcinoma in sub-Saharan Africa. Nig J Gastroenterol Hepatol 2009, 1:7-13.
14. Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 2009, 27:1485.
15. Lyamuya EF, Aboud S, Urassa WK, Sufi J, Mbwana J, Ndungulile F, Massambu C. Evaluation of rapid HIV assays and development of national rapid HIV test algorithms in Dar es salaam. Tanzan BMC Infect Dis 2009, 9:19.
16. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, Nakajima Y, Ohnishi K. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985, 56:918-928.
17. El-Zayadi AR, Badran HM, Barakat EMF, Attia MED, Shawky S, Mohamed MK, Selim O, Saeid A. Hepatocellular carcinoma in Egypt: a single centre study over a decade. World J. Gastroenterol 2005, 11:5193-5198.
18. Ozer B, Serin E, Yilmaz U, Gümürdülü Y, Saygili OB, Kayaselçuk F, Boyacioǧlu. Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey. Turk J Gastroenterol 2003, 14:85-90.
19. Wands J. Hepatocellular carcinoma and sex. N Engl J Med 2007, 19:1974-1976.
20. Yu MW, Chang HC, Chang SC. Role of reproductive factors in hepatocellular carcinoma: impact on hepatitis B and C-related risk. Hepatology 2003, 38:1393-1400.
21. Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, Karin M. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007, 317:121-124.
22. Kasahara A, Hayashi N, Mochizuki K, Takayanagi M, Yoshioka K, Kakumu S, Iijima A, Urushihara A, Kiyosawa K, Okuda M, Hino K, Okita K. Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group. Hepatol 1998, 27:1394-1402.
23. Kumar M, Kumar R, Hissar SS, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India. J Gastroenterol Hepatol 2007, 22:1104-1011.
24. Valizadeh N, Mehdioghli R, Behroozian R. Etiologic and epidemiologic study of hepatocellular carcinoma in West Azarbaijan of Iran (2006-2011). Indian J Med Paediatr Oncol 2012, 33:221-223.
25. T Andreone P, Andriulli A, Ascione A, Craxi A, Chiaramonte M, Galante D, Manghisi OG, Mazzanti R, Medaglia C, Pilleri G, Rapaccini GL, Simonetti RG, Taliani G, Tosti ME, Villa E, Gasbarrini G. Characteristics of hepatocellular carcinoma in Italy. J Hepatol 1998, 29:944-952.
26. Salem AK, Abdulrab A, Alfakeh Y, Aown A. Hepatocellular carcinoma in Yemeni patients: a single centre experience over an 8-year period. EMHJ 2012, 18:693-699.
27. McGlynn K, London W. Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 2005, 19:3-23.
28. DiBisceglie AM, Order SE, Klein JL. The role of chronic viral hepatitis in hepatocellular carcinoma in the United States. Am J Gasroenterol 1991, 86:335-338.
29. Bruix J, Barrera JM, Calvet X. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and liver cirrhosis. Lancet 1989, 3:104-106.
30. Nishioka K, Watanabe J, Furata S. A high prevalence of antibody to hepatitis C virus in hepatocellular carcinoma patients in Japan. Cancer 1991, 67:423-438.
31. Tsega E. Hepaocellular carcinoma in Ethiopia: a prospective clinical study of 100 patients. E Afr Med J 1977, 54:281-291.
32. Urassa M, Isingo R, Kumogola Y, Mwidunda P, Helelwa M, Changulucha J, Mngara J, Zaba B, Calleja T, Slaymaker E. Effect of PMTCT availability on choice of ANC in Mwanza and Magu districts and its impact on HIV sentinel surveillance in Tanzania 2007, 2007 Report of ANC surveillance Mwanza and Magu Districts.
33. Nzeako UC, Goodman ZD, Ishak KG. Comparison of tumor pathology with duration of survival of North American patients with hepatocellular carcinoma. Cancer 1995, 76:579-588.
34. Llovet JM, Burroughs A, Bruix J. Novel advancements in the management of HCC in 2008. J Hepatol 2008, 48:S20-S37.
35. Lescano M, Carneiro M, Elias Junior J, Martinelli A, França A. Experiences and evaluation of withhepatocellular carcinoma in a tertiary Hospital. Gastroenterología y Hepatología 2002, 25(Suppl 2):I-9-I-43.
36. Nwokediuko SC, Ijoma UN, Obienu O. Liver cancer, South East Nigeria. Insight Bioinformatics 2011, 1:1-5.
37. Fasani PA, Sangiovanni C, de Fazio M, Bozio S, Bruno S. High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors. Hepatology 1999, 29:1704-1707.
38. Olubuyide IO. The natural history of primary liver cell carcinoma: a study of 89 untreated adult Nigerians. Centr Afr J Med 1992, 38:25-29.
39. Ajayi AO, Ajayi EA, Komolafe OA. Hepatocellular carcinoma: Risk factors, pattern of presentation and outcome in a tertiary health facility. Int J Med Med Sci 2009, 1:84-87.